Improvements in systemic insulin sensitivity in humans treated with anti-TNF-α therapies for inflammatory diseases like rheumatoid arthritis also suggest a potential therapeutic role for TNF-α [73]. This evidence concerns the gene TNF and rheumatoid arthritis.